Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Warts 2Whooping Cough 1Pneumococcal Infections 1Papillomavirus Infections 1Neoplasms 1Neoplasm Metastasis 1Measles 1Hepatitis B 1HIV Infections 1

Interventions

Cryotherapy 7resiquimod 6Cantharidin 4Cholecalciferol 3PRA1 protein, Candida albicans 2N-phenylacetoaminomethylene-DL-p-nitrophenylalanine 2Measles-Mumps-Rubella Vaccine 22-Propanol 2plerixafor 1methyl 5-aminolevulinate 1lactic acid, salicylic acid drug combination 1green tea extract polyphenone E 1gluconic acid 1ammonium trichloro(dioxoethylene-O,O'-)tellurate 1VP-102 1Tuberculin 1Trichloroacetic Acid 1Sugars 1Starch 1Photochemotherapy 1Nitric Oxide 1Mass Screening 1Maltose 1Lasers, Solid-State 1Lasers 1Interferon-alpha 1Imiquimod 1Human Papillomavirus Recombinant Vaccine nonavalent 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Granulocyte Colony-Stimulating Factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Warts × Measles-Mumps-Rubella Vaccine × Clear all
NCT04428359 2021-04-09

MMR

B.P. Koirala Institute of Health Sciences

Phase NA Completed
66 enrolled 16 charts

Warts

NCT03183765 2020-06-16

Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts

Assiut University

Phase 4 Completed
48 enrolled

Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡